AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks

RESMED INC (RMD)

Latest AI Signal: SELL
Status: EXPIRED
Days Old: 28

Confidence: 65.00%

Date: 23-04-2026

Price: $30.760

Last Price: $29.260

Post-Signal Low Price: $27.660


Latest  RESMED INC(RMD)   News

22 Apr 2025, 10:02 PM

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. ResMed beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $1.28 billion, up 10.3

22 Apr 2025, 07:00 AM

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Resmed, Inc. Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care del

22 Apr 2025, 12:00 AM

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

The market expects InMode (INMD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its ne

17 Apr 2025, 11:15 PM

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Wall Street analysts forecast that ResMed (RMD) will report quarterly earnings of $2.36 per share in its upcoming release, pointing to a year-over-year increase of 10.8%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 7.3% compared to the year-ago quarter. T

17 Apr 2025, 12:00 AM

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when ResMed (RMD) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock p



Sell Confidence Medium

AI Confidence - 65.00 % model confidence